Last reviewed · How we verify

NCT06963489: CLOMB

Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort

Recruiting now Last updated 11 May 2025
What this trial tests

trial testing Not applicable- observational study in Large Vessel Occlusion in 500 participants. Currently enrolling.

Timeline
27 April 2025
Primary endpoint
29 February 2028
29 February 2028

Quick facts

Lead sponsorFirst Affiliated Hospital of Wannan Medical College
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment500
Start date27 April 2025
Primary completion29 February 2028
Estimated completion29 February 2028
Sites5 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

First Affiliated Hospital of Wannan Medical College

Who can join

Eligibility, any sex, with Large Vessel Occlusion or Acute Ischemic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This multicenter, ambispective cohort study establishes a comprehensive multiomics biobank from five stroke centers, encompassing thrombi, intracranial blood, peripheral arterial/venous blood, and clinical-laboratory-imaging-follow-up data from patients with acute ischemic stroke with large vessel occlusion (AIS-LVO).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Not applicable- observational study

Trials testing the same drug.

Other recruiting trials for Large Vessel Occlusion

Currently open trials in the same condition.

Other First Affiliated Hospital of Wannan Medical College trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06963489.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing